News
According to the latest study from BCC Research, the "Cancer Immunotherapy: Technologies and Global Markets" is expected to ...
BCG therapy—the gold standard treatment for non-muscle invasive bladder cancer (NMIBC), where the cancer has not penetrated ...
Tumors are heterogenous masses of cells that rapidly divide. Many cells have different mutations, functions, and ways to ...
On June 26, the BC Cancer Foundation announced that Dr. Brad Nelson will become the inaugural Lynda and Murray Farmer ...
A new preclinical study unveils a more powerful and effective immunotherapy for bladder cancer and other solid tumours.BCG ...
The immune system is central to identifying and eliminating foreign pathogens that enter the body. The innate and adaptive immune responses work together t | Immunology ...
Lung cancer remains the leading cause of cancer mortality worldwide. Immunotherapy has recently emerged as a promising therapeutic strategy both for ...
Camille Casson Embry, 51, said her oncologist stepped in to help her get the life-saving drug she needed completely covered.
House Bill 3057 removes barriers for rural cancer centers to offer CAR T therapy, reducing travel strain for patients and ...
I entered remission from lung cancer 5.5 years ago, but faced a tough road readjusting, with ongoing physical, mental and ...
Despite her commitment to fitness, Bianca Harvey received a life-altering cancer diagnosis at age 34. Now Harvey's treatment has her cancer shrinking by over 50%, offering hope for remission.
Senhwa Biosciences, Inc. (TPEx: 6492), a clinical-stage biopharmaceutical company, held its 2025 Annual Shareholders' Meeting today, chaired by Chairman Mr. Benny T. Hu. The company delivered updates ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results